Crestwood Advisors Group LLC Agenus Inc Transaction History

Crestwood Advisors Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$4.98 - $6.63 $43,575 - $58,012	-8,750 Reduced 20.99%	32,928 $173,000
Q1 2021 Apr 21, 2021	BUY	$2.69 - $5.25 $9,415 - $18,375	3,500 Added 9.17%	41,678 $113,000
Q4 2020 Feb 09, 2021	BUY	$3.17 - $4.49 $16,642 - $23,572	5,250 Added 15.94%	38,178 $121,000
Q3 2017 Nov 20, 2017	BUY	$3.48 - $4.44 $114,589 - $146,200	32,928	32,928 $145,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

Stay updated on Crestwood Advisors Group LLC with notifications on news.